Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：7.033 Date：2023-01-05

International Journal of Nanomedicine

Exosomal miR-133a-3p Derived from BMSCs Alleviates Cerebral Ischemia-Reperfusion Injury via Targeting DAPK2

Products： BC009、 BC021、 ELK1928、 ELK2236、 ELK5615、 ELK7832、 EP013、 EQ001
IF：7 Date：2024-03-14

antioxidants

Norcantharidin Sensitizes Colorectal Cancer Cells to Radiotherapy via Reactive Oxygen Species–DRP1-Mediated Mitochondrial Damage

Products： BC046
IF：7 Date：2024-12-10

BMC Medicine

Exacerbated ischemic brain damage in type 2 diabetes via methylglyoxal-mediated miR-148a-3p decline

Products： ELK10251
IF：7 Date：2025-01-21

COMPUTERS IN BIOLOGY AND MEDICINE

Integrative multi-omics analysis of Crohn's disease and metabolic syndrome: Unveiling the underlying molecular mechanisms of comorbidity

Products： EP013

< Page of 331 >